With regard to Medicago, Philip Morris International and the government's investments in Medicago: (a) what are the details of all memorandums, correspondence or briefing materials sent to or received by any minister, exempt staff, or government official in any department or agency in the Health portfolio or the Innovation, Science and Economic Development portfolio, since January 1, 2020, about Medicago or Philip Morris International, including, for each, the (i) type of document, (ii) date, (iii) sender, (iv) recipient, (v) title, (vi) subject matter, (vii) summary of contents, (viii) file number; (b) on what date was the government made aware that Philip Morris' minority ownership stake in Medicago's parent company would make its products ineligible to receive authorization from the World Health Organization; and (c) did the government do anything to hedge its investments following the realization in (b)?
In the House of Commons on March 27th, 2023. See this statement in context.